SCHEMBL14007196

SCHEMBL14007196

CC(C)NC(=O)c1ccc(=O)n(CC(=O)N2CCOCC2)c1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 2/20 0.47
KMT2A Q03164 3/20 0.45
POLB P06746 1/20 0.45
SMN1; SMN2 Q16637 3/20 0.43
ALDH1A1 P00352 2/20 0.43
GAA P10253 1/20 0.43
MDM2 Q00987 1/20 0.43
TSHR P16473 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43
RAB9A P51151 1/20 0.42
PKM P14618 1/20 0.42
FKBP1A P62942 1/20 0.41
MEN1 O00255 2/20 0.41
NPSR1 Q6W5P4 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
PIN1 Q13526 1/20 0.41
HDAC6 Q9UBN7 1/20 0.40
PTGS2 P35354 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13702171 0.90 POLB (0.51) HRH3KMT2APOLBSMN1; SMN2ALDH1A1
SCHEMBL13702164 0.89 HRH3 (0.48) HRH3KMT2APOLBSMN1; SMN2ALDH1A1
SCHEMBL13702308 0.85 ALDH1A1 (0.49) KMT2APOLBSMN1; SMN2ALDH1A1GAA
SCHEMBL14007204 0.84 HRH3 (0.58) HRH3POLBSMN1; SMN2ALDH1A1GAA
SCHEMBL13701815 0.84 MEN1 (0.44) KMT2ASMN1; SMN2ALDH1A1GAARXFP1
SCHEMBL13702182 0.81 ALDH1A1 (0.57) HRH3KMT2APOLBSMN1; SMN2ALDH1A1
SCHEMBL4249071 0.81 GAA (0.49) KMT2APOLBSMN1; SMN2ALDH1A1GAA
SCHEMBL14034428 0.80 GAA (0.46) KMT2APOLBSMN1; SMN2ALDH1A1GAA
SCHEMBL13702178 0.78 HRH3 (0.51) HRH3POLBSMN1; SMN2ALDH1A1TSHR
SCHEMBL14007252 0.78 EPHX2 (0.56) KMT2ASMN1; SMN2ALDH1A1TSHRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080280904-A1 N-Substituted Pyridinone or Pyrimidinone Compounds Useful as Soluble Epoxide Hydrolase Inhibitors ELDRUP ANNE BETTINA 2008-11-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080280904-A1 N-Substituted Pyridinone or Pyrimidinone Compounds Useful as Soluble Epoxide Hydrolase Inhibitors EPHX1, EPHX2, DOHH HRH3 114/4885KMT2A 3400/4885POLB 1051/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.